<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005086.pub4" GROUP_ID="INCONT" ID="006304072811065843" MERGED_FROM="" MODIFIED="2015-07-03 15:28:56 +0100" MODIFIED_BY="Muhammad Imran Omar" REVIEW_NO="1" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2015-07-03 15:28:56 +0100" MODIFIED_BY="Muhammad Imran Omar">
<TITLE>Plugs for containing faecal incontinence</TITLE>
<CONTACT MODIFIED="2015-07-03 15:28:56 +0100" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="D32911FD82E26AA20080535F75195A7D" ROLE="AUTHOR"><FIRST_NAME>Marije</FIRST_NAME><LAST_NAME>Deutekom</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Epidemiologist</POSITION><EMAIL_1>marije@baartdelafaille.nl</EMAIL_1><ADDRESS><DEPARTMENT>Department of Social Medicine k2-207</DEPARTMENT><ORGANISATION>Academic Medical Center</ORGANISATION><ADDRESS_1>Meibergdreef 9</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1105 AZ</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 20 5664684</PHONE_1><FAX_1>+31 20 6972316</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-07-03 15:28:56 +0100" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="D32911FD82E26AA20080535F75195A7D" ROLE="AUTHOR"><FIRST_NAME>Marije</FIRST_NAME><LAST_NAME>Deutekom</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Epidemiologist</POSITION><EMAIL_1>marije@baartdelafaille.nl</EMAIL_1><ADDRESS><DEPARTMENT>Department of Social Medicine k2-207</DEPARTMENT><ORGANISATION>Academic Medical Center</ORGANISATION><ADDRESS_1>Meibergdreef 9</ADDRESS_1><CITY>Amsterdam</CITY><ZIP>1105 AZ</ZIP><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 20 5664684</PHONE_1><FAX_1>+31 20 6972316</FAX_1></ADDRESS></PERSON><PERSON ID="D32912C882E26AA20080535FCA20B9F3" ROLE="AUTHOR"><FIRST_NAME>Annette</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Dobben</LAST_NAME><EMAIL_1>ac.bruijne@igz.nl</EMAIL_1><ADDRESS><DEPARTMENT>Academic Medical Center</DEPARTMENT><ORGANISATION>Department of Radiology, G1-223</ORGANISATION><ADDRESS_1>PO Box 22700</ADDRESS_1><CITY>1100 DE Amsterdam</CITY><COUNTRY CODE="NL">Netherlands</COUNTRY><PHONE_1>+31 20 566 7500</PHONE_1><FAX_1>+31 20 566 9210</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-06-08 22:31:35 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="26" MONTH="5" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="26" MONTH="5" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="25" MONTH="5" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2015-07-03 15:27:20 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-07-03 15:27:08 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="7" YEAR="2015"/>
<DESCRIPTION>
<P>A search of the Incontinence Review Group Specialised Trials Register was performed on 26th May 2015 but did not identify any new trial.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-07-03 15:27:20 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="7" YEAR="2015"/>
<DESCRIPTION>
<P>A search of the Incontinence Review Group Specialised Trials Register was performed on 26th May 2015 but did not identify any new trial.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-06-15 13:43:08 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-08 22:31:57 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>A search of the Incontinence Review Group Specialised Trials Register was performed on 29th February 2012 but no new trials were found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2015-06-08 22:32:00 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="2" YEAR="2012"/>
<DESCRIPTION>
<P>A search of the Incontinence Review Group Specialised Trials Register was performed on 29th February 2012 but no new trials were found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-15 13:43:00 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="7" YEAR="2009"/>
<DESCRIPTION>
<P>

New search, no new trials.
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-16 13:09:16 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-06-15 13:43:03 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="8" YEAR="2006"/>
<DESCRIPTION>
<P>A search of the Incontinence Group Specialised Trials Register was performed on 29 May 2006 but no new trials were found. For this update of the review one of the trials (Van Winckel 2005) has now been published but did not add any extra data to the unpublished data provided by the author for the original version of this review.
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2015-06-15 13:43:08 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="5" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment.
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-06-17 11:02:13 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2015-06-17 11:02:13 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-06-17 11:02:13 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Incontinence.</P>
<P>
<U>Disclaimer</U>:<BR/>The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-06-16 12:26:00 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2015-06-16 11:40:50 +0100" MODIFIED_BY="[Empty name]">
<TITLE>Plugs for preventing the loss of stool in patients with faecal incontinence</TITLE>
<SUMMARY_BODY MODIFIED="2015-06-16 11:40:50 +0100" MODIFIED_BY="[Empty name]">
<P>Faecal incontinence is defined as the involuntary passage of faecal material through the anal canal and is a common and embarrassing problem. Different treatments exist, including dietary measures, drugs, specialized physiotherapy of the pelvic floor, and surgery. However, not all patients can be cured. These patients might be helped by using anal plugs. Different types of anal plugs are known, all aiming to block the loss of stool to control their incontinence. The aim of this review was to assess the performance of different types of anal plugs for containment of faecal incontinence.</P>
<P>Four studies with a total of 136 participants were included. Two studies compared the use of plugs versus no plugs. The involuntary loss of stool was effectively blocked (pseudo-continence) in six (38%) participants who continued to use the plugs, at least in the short-term. One study compared two sizes of the same brand of plug; due to the high dropout in this study and the incomplete data, no results concerning this comparison are available. In one study a comparison of two different brands of plug was made. Loss of plug was reported by 7 patients (30%) with a polyurethane (PU) plug and by 15 patients (65%) with the polyvinyl-alcohol (PVA) plug. Overall satisfaction, defined as patients' opinion that the plug was good to very good, was reported more often for the PU plug (n = 17) than for the PVA plug (n = 8).</P>
<P>In all included studies there was considerable dropout; in total 48 participants (35%) dropped out before the end of the study for varying reasons. Data presented are thus subject to potential bias, and only tentative conclusions are possible. The available data suggest that anal plugs can be difficult to tolerate. However, if they are tolerated they can be helpful in preventing incontinence. Plugs could then be useful in a selected group of people either as a substitute for other forms of management or as an adjuvant treatment option. Plugs come in different designs and sizes; the review showed that the selection of the type of plug can impact on its performance.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-06-16 11:40:41 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Faecal incontinence is a distressing disorder with high social stigma. Not all people with faecal incontinence can be cured with conservative or surgical treatment and they may need to rely on containment products, such as anal plugs.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the performance of different types of anal plugs for containment of faecal incontinence.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-06-16 11:40:37 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Incontinence Group Specialised Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, ClinicalTrials.gov, World Health Organization (WHO) ICTRP and handsearching of journals and conference proceedings (searched 26 May 2015). Reference lists of identified trials were searched and plug manufacturers were contacted for trials. No language or other limitations were imposed.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-06-16 11:40:41 +0100" MODIFIED_BY="[Empty name]">
<P>Types of studies: this review was limited to randomised and quasi-randomised controlled trials (including crossovers) of anal plug use for the management of faecal incontinence.</P>
<P>Types of participants: children and adults with faecal incontinence.</P>
<P>Types of interventions: any type of anal plug. Comparison interventions might include no treatment, conservative (physical) treatments, nutritional interventions, surgery, pads and other types or sizes of plugs.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two reviewers independently assessed methodological quality and extracted data from the included trials. Authors of all included trials were contacted for clarification concerning methodological issues.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Four studies with a total of 136 participants were included. Two studies compared the use of plugs versus no plugs, one study compared two sizes of the same brand of plug, and one study compared two brands of plugs. In all included studies there was considerable dropout (in total 48 (35%) dropped out before the end of the study) for varying reasons. Data presented are thus subject to potential bias. 'Pseudo-continence' was, however, achieved by some of those who continued to use plugs, at least in the short-term. In a comparison of two different types of plug, plug loss was less often reported and overall satisfaction was greater during use of polyurethane plugs than polyvinyl-alcohol plugs.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>The available data were limited and incomplete, and not all pre-specified outcomes could be evaluated. Consequently, only tentative conclusions are possible. The available data suggest that anal plugs can be difficult to tolerate. However, if they are tolerated they can be helpful in preventing incontinence. Plugs could then be useful in a selected group of people either as a substitute for other forms of management or as an adjuvant treatment option. Plugs come in different designs and sizes; the review showed that the selection of the type of plug can impact on its performance.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-06-16 12:26:00 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-06-16 11:41:29 +0100" MODIFIED_BY="[Empty name]">
<P>Faecal incontinence is defined as the involuntary passage of faecal material through the anal canal (<LINK REF="REF-Soffer-2000" TYPE="REFERENCE">Soffer 2000</LINK>). The reported prevalence values range from 1.4% in the general population (defined as soiling of underwear, outer clothing, furnishing, or bedding several times a month or more often) (<LINK REF="REF-Perry-2002" TYPE="REFERENCE">Perry 2002</LINK>); to 46% in institutionalised elderly people (defined as at least one incontinent episode per week) (<LINK REF="REF-Borrie-1992" TYPE="REFERENCE">Borrie 1992</LINK>). It is possible that the real prevalence is even higher than reported as faecal incontinence is associated with high social stigma and people are reluctant to seek help for this disorder because of embarrassment (<LINK REF="REF-Jorge-1993" TYPE="REFERENCE">Jorge 1993</LINK>; <LINK REF="REF-Mavrantonis-1998" TYPE="REFERENCE">Mavrantonis 1998</LINK>).</P>
<P>The causes for faecal incontinence are diverse. In most cases a combination of factors leads to incontinence. Frequently cited causes are injuries during childbirth and prior anorectal surgery (<LINK REF="REF-Kamm-1998" TYPE="REFERENCE">Kamm 1998</LINK>; <LINK REF="REF-Toglia-1998" TYPE="REFERENCE">Toglia 1998</LINK>). But many other causes have been described, including loose stool, intestinal hurry, and neurological disease or injury.</P>
<P>Treatments available range from conservative therapy, such as dietary recommendations and anti-diarrhoeal medication, to surgical treatment by either sphincter repair, dynamic graciloplasty, artificial anal sphincter implantation, or sacral nerve stimulation (<LINK REF="REF-Jorge-1993" TYPE="REFERENCE">Jorge 1993</LINK>; <LINK REF="REF-Matzel-2003" TYPE="REFERENCE">Matzel 2003</LINK>). Nowadays, the most common treatments are pelvic floor muscle training - with or without biofeedback - and anterior anal sphincter repair (<LINK REF="REF-Kamm-1998" TYPE="REFERENCE">Kamm 1998</LINK>). The reported success rates with these forms of treatment vary, but it is recognized that none of the treatments will resolve the incontinence problems in all patients. Cochrane reviews are available that cover some of these treatments: these include drug treatment (<LINK REF="REF-Omar-2013" TYPE="REFERENCE">Omar 2013</LINK>); electrical stimulation, sphincter exercises and biofeedback (<LINK REF="REF-Hosker-2007" TYPE="REFERENCE">Hosker 2007</LINK>; <LINK REF="REF-Norton-2012" TYPE="REFERENCE">Norton 2012</LINK>); sacral nerve stimulation (<LINK REF="REF-Mowatt-2007" TYPE="REFERENCE">Mowatt 2007</LINK>); surgery (<LINK REF="REF-Brown-2013" TYPE="REFERENCE">Brown 2013</LINK>); and management of faecal incontinence and constipation in adults with central neurological diseases (<LINK REF="REF-Coggrave-2014" TYPE="REFERENCE">Coggrave 2014</LINK>).</P>
<P>Where incontinence persists despite active treatment there may be no option other than containment. <LINK REF="REF-Brazzelli-2002" TYPE="REFERENCE">Brazzelli 2002</LINK> have reviewed the use of pads for the containment of anal and urinary incontinence. There is also a Cochrane review covering this topic (<LINK REF="REF-Fader-2008" TYPE="REFERENCE">Fader 2008</LINK>). Problems when using pads for faecal incontinence are that the odour from the anal leakage is difficult to control and extensive use of pads can result in skin condition problems. A possible way to avoid these problems is the use of an anal plug (sometimes called 'tampon'): a device specially developed for containing faecal incontinence.</P>
<P>Different types of anal plugs are known, all aiming to block the loss of stool. They were first used in patients suffering from faecal incontinence due to major neurological problems, such as caused by spina bifida (<LINK REF="REF-Norton-2001a" TYPE="REFERENCE">Norton 2001a</LINK>). Nowadays, plugs are also sometimes used by patients with faecal incontinence who do not have an underlying neurological condition.</P>
<P>At this point it is unclear how effective anal plugs are in controlling stool loss in patients with faecal incontinence (with or without neurological impairments) and whether some types of anal plugs are more effective than others. This review aims to bring together in a systematic way the best available evidence to address these issues.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the performance of different types of anal plugs for containment of faecal incontinence.</P>
<P>The following comparisons were considered:<BR/>1. anal plugs versus no plugs;<BR/>2. one type of anal plug versus another;<BR/>3. anal plugs versus any other treatment.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-06-16 12:26:00 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-06-16 11:42:35 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>This review was limited to randomised and quasi-randomised controlled trials (including crossovers) of anal plug use for the management of faecal incontinence.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>All patients (children and adults) with faecal incontinence.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Studies investigating the relative performance of anal plugs. Potential comparison interventions include no treatment, conservative (physical) treatments, nutritional interventions, surgery, pads, and other types or sizes of plugs.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-06-16 11:42:35 +0100" MODIFIED_BY="[Empty name]">
<P>1. Patient symptoms:<BR/>
</P>
<UL>
<LI>frequency of incontinence of stool or flatus (diary or self-report);</LI>
<LI>degree of incontinence (e.g. stool weight);</LI>
<LI>incontinence score;</LI>
<LI>episodes of anal urgency.</LI>
</UL>
<P>
<BR/>2. Physical measures:<BR/>
</P>
<UL>
<LI>achievement of pseudo-continence (continence only while wearing a plug);</LI>
<LI>wearing time and frequency of use;</LI>
<LI>leakage rate;</LI>
<LI>odour control.</LI>
</UL>
<P>
<BR/>3. Patient satisfaction:<BR/>
</P>
<UL>
<LI>satisfaction with incontinence-controlling capacity;</LI>
<LI>tolerability of plug (including persistence in using the plug);</LI>
<LI>comfort of plug in use;</LI>
<LI>comfort of plug removal/ease of removal;</LI>
<LI>feeling of cleanness.</LI>
</UL>
<P>
<BR/>4. Health status measures:<BR/>
</P>
<UL>
<LI>impact of incontinence on health status, social life, and quality of life.</LI>
</UL>
<P>
<BR/>5. Costs</P>
<P>6. Other outcomes:<BR/>
</P>
<UL>
<LI>non pre-specified outcomes later judged important when performing the review.</LI>
</UL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-06-16 11:42:54 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2015-06-16 11:42:54 +0100" MODIFIED_BY="[Empty name]">
<P>We formulated a comprehensive and exhaustive search strategy in an attempt to identify all relevant studies regardless of language or publication status (published, unpublished, in press, and in progress).</P>
<P>This review has drawn on the search strategy developed for the Cochrane Incontinence Group. Relevant trials were identified from the Group's Specialised Register of Trials, which is described under the Group's <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/INCONT/frame.html">module</A> in the Cochrane Library. The Register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and MEDLINE In-Process, ClinicalTrials.gov, WHO ICTRP and handsearching of journals and conference proceedings.</P>
<P>The Incontinence Group Specialised Register was searched using the Group's own keyword system. The search terms used are given in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The date of the most recent search of the register for this review: 26 May 2015.</P>
<P>For the first published version of this review the authors performed additional searches which are detailed in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-06-25 14:12:56 +0100" MODIFIED_BY="[Empty name]">
<P>Additionally all reference lists of identified trials were searched. We contacted two manufacturers that marketed plugs to ask for details of unpublished or ongoing trials. We did not impose any language or other limitations on the searches.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-06-16 12:26:00 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Study selection</HEADING>
<P>Two reviewers assessed the title and abstract of references identified by the search strategy. The full reports of all potentially eligible randomised and quasi-randomised controlled trials were then obtained for further assessment of eligibility. Any disagreements were resolved by discussion. Studies were only included if they were randomised or quasi-randomised trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Methodological quality assessment</HEADING>
<P>The quality of eligible trials was assessed independently by the two reviewers using a pre-defined quality assessment form (see details under the Incontinence Group in <I>The Cochrane Library</I>). Reviewers were not blind to author, institution or journal. Disagreements between reviewers were resolved by discussion. Studies were not excluded from the review on the basis of methodological quality.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data abstraction</HEADING>
<P>Relevant data regarding inclusion criteria (study design, participants, interventions and outcomes), quality criteria (randomisation and blinding), and results were extracted independently by the two reviewers using a data abstraction form adapted from the form designed by the Dutch Cochrane Centre. In cases where insufficient data were reported authors were contacted for further information (such as method of randomisation, statistical methods).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data analysis</HEADING>
<P>Data were analysed using the MetaView statistical software in Review Manager 4.2.5 (<LINK REF="REF-RevMan-2003" TYPE="REFERENCE">RevMan 2003</LINK>). For dichotomous variables, risk ratios (RR) and 95% confidence intervals (CI) were derived for each outcome. It was not possible to combine data from the included studies as outcomes, and type of comparisons varied. We instead present a qualitative synthesis of the results of the primary studies.</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-06-16 11:45:56 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-06-16 11:43:48 +0100" MODIFIED_BY="[Empty name]">
<P>The search strategy identified 13 potentially eligible studies. When full citations were obtained nine studies could not be included: seven were patient series, one was a case study, and one study was excluded as we understood from the author that this paper did not report a randomised trial.</P>
<P>Thus in total, four studies met our inclusion criteria (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>; <LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). Two of these studies were derived from the Specialised Trials Register of the incontinence group (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>). One was derived by the additional searches performed by one of the authors (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>). The final trial was obtained by contacting an anal plug manufacturer (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>).</P>
<P>The reports of <LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK> and <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>, two of the included trials, had not been published at the time of finishing the original version of the review (<LINK REF="REF-Deutekom-2005" TYPE="REFERENCE">Deutekom 2005</LINK>) . We received permission from the authors to use their data in our review. For the 2010 update of the review (2010, Issue 1 search updated but no new citation) one of the trials had been published but did not add any extra data to that provided by the author for the original version of this review (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). For the 2012 update the published journal article for <LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK> was available but again this did not add any extra data to that provided by the author for the original version of this review. The flow of literature through the assessment process is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>The total number of participants across the trials was 136. For a detailed description of individual studies please refer to the table of <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Design</HEADING>
<P>Three studies used a randomised crossover designs (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>); and one was a parallel group randomised controlled trial (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sample size</HEADING>
<P>Sample sizes were 16 (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>); 34 (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>); 38 (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>); and 48 (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Diagnosis</HEADING>
<P>All studies included patients with faecal incontinence.<BR/>One study included patients who were partially continent or incontinent following imperforate anus repair (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>). One study included children who had faecal incontinence due to a high type imperforate anus and children with spina bifida (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). One study included children (older than 4 years) and young adults (16 to 45 years) who were incontinent due to congenital or acquired neurogenic disorders (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>); and one included adult outpatients after failure of previous treatment (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Location/setting</HEADING>
<P>One trial was carried out in Scotland and participants were identified primarily by hospital specialists from Paediatric Surgery or Gastroenterology in Aberdeen, Inverness and Glasgow (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). One trial was carried out in Germany in a hospital for Paediatric Surgery (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>); one in Belgium at the departments of Paediatrics and Urology in an academic medical centre (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>); and one in England in a specialist colorectal hospital where patients received an individual instruction with a nurse specialist (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Interventions</HEADING>
<P>The four identified trials made the following comparisons:</P>
<P>1. anal plug versus no plug (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>);</P>
<P>2-I. one type of anal plug versus another: comparison of two sizes of the same type of plug (polyurethane anal plug) (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>);</P>
<P>2-II. one type of anal plug versus another: comparison of two different types of plugs (polyurethane anal plug versus polyvinyl-alcohol plug) (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Length of treatment</HEADING>
<P>Three trials lasted between four and six weeks (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). One trial lasted one year (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>Common reported outcomes were frequency of incontinent episodes (effectiveness of treatment), satisfaction and tolerance.</P>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-06-16 11:44:53 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Potential for selection bias at trial entry</HEADING>
<P>In all crossover trials the order of the intervention was randomised (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). In none of these studies were details provided concerning the methods used for randomisation and concealment. In the parallel group randomised controlled trial the participants were randomly allocated to the intervention or control group (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). Randomisation was performed using pre-determined codes.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Potential for bias at time of treatment or outcome assessment</HEADING>
<P>As the studies included in this review investigated anal plugs it is difficult to blind patients and staff to intervention. In two studies the use of plugs was compared to a control intervention in which patients did not receive any treatment (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>): blinding was impossible. In the remaining two randomised crossover studies two types or two sizes of plugs were compared (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>). Neither study reported any blinding.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Potential for bias in trial analysis</HEADING>
<P>In three studies the number and reasons for patient dropouts were clearly described (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>).<BR/>
</P>
<UL>
<LI>In one study 23 of the 34 (68%) patients did not start or dropped out (Norton 2001b). Reasons why patients dropped out were: they disliked the idea and did not start the study (n = 4); they failed to attend the clinic (n = 2); they dropped out because of discomfort after trying the first plug (n = 8); and they dropped out after trying one size of plug, refusing to try the second one (n = 9).</LI>
<LI>In one study 15 of the 38 patients (39%) dropped out before the end of the study (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>). Two patients liked the first tested product and ended participation; six patients found the smallest available size of the products (tested first) to be too big; two patients reported discomfort; one patient constantly lost one of the products; and four patients failed to complete the protocol for non-plug related reasons.</LI>
<LI>In one study 4 of the 16 patients dropped out (25%) (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). Reported reasons for this were discomfort and pain (n = 2); and losing the plug (n = 2).</LI>
<LI>In one study 6 patients dropped out from the 48 included, but did not report any reasons for this (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). All those who dropped out were in the intervention group.</LI>
</UL>
<P>
<BR/>In only one of the studies was an intention-to-treat analysis performed (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). In none of the trials was there a description whether data analysis was performed blindly.</P>
</SUBSECTION>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-06-16 11:45:56 +0100" MODIFIED_BY="[Empty name]">
<P>Three randomised crossover trials and one randomised controlled trial were included in this review. As the reported outcome measures varied amongst trials, a quantitative synthesis of the results was not feasible. In the summary tables 'N' denotes the total number of patients and 'n' denotes the number of patients who had the outcome. Unfortunately the data from the randomised crossover studies were not presented in a form suitable for inclusion in the formal analysis.</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1: anal plugs versus no plugs</HEADING>
<P>Two of the included studies compared the use of anal plugs with standard treatment (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). In both studies patients were allowed to choose their preferred size of plug. In both trials a choice could be made between small or larger Coloplast plugs.</P>
<SUBSECTION>
<HEADING LEVEL="4">Patient symptoms</HEADING>
<P>Pseudo-continence was reported in six out of 16 patients in the treatment period in the crossover study, and in none of the 16 during the control period (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). Patients achieving pseudo-continence were reported to show greater satisfaction with treatment during plug use (no further data provided by the author) than when not using a plug (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). Three of the 16 patients (two with anal atresia and one with spina bifida) continued using the plug after the study. Neither stool frequency nor stool consistency was affected by use of the plug (no further data provided by the author). In the parallel group trial, clinically derived condition-specific measures (such as protection, rash/skin problems, and unpleasant odour) tended to favour the plugs group for all patients (adults and children) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), although no difference was statistically significant, confidence intervals were wide, and dropout rates were considerable (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Patient satisfaction</HEADING>
<P>In the randomised crossover trial four patients did not complete the treatment period due to discomfort and pain (n = 2; anal atresia) and losing of the plug (n = 2; spina bifida) (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). The plug was thus not tolerated in four out of 16 patients. All patients tolerated the control period (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Health status measures</HEADING>
<P>
<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK> reported data for adults on changes in general health (3/14 versus 0/5; risk ratio (RR) was 2.63 (95% confidence interval (CI) 0.16 to 43.63) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>)); bodily pain (6/15 versus 3/5; (RR 0.67, 95% CI 0.26 to 1.72) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>)); and various measures of well being (derived from SF-36) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Confidence intervals were all wide, reflecting the small numbers studied.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Costs</HEADING>
<P>Little or no evidence was obtained that the plug led to significant reductions in the overall costs of care (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>).</P>
<P>No data were available for the other pre-specified outcomes (see Table of comparisons).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2-I: one type of anal plug versus another (comparison of two sizes)</HEADING>
<P>One study compared two sizes of a plug in a randomised crossover design (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>). Due to the high dropout in this study and the incomplete data, no results concerning the comparison are available.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2-II: one type of anal plug versus another (comparison of two types)</HEADING>
<P>One study compared two types of plugs in a randomised crossover design: polyurethane anal plug (Conveen, Coloplast) (PU plug) versus EFF-EFF polyvinyl-alcohol plug (Med. SSE-System) (PVA plug) (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Patient symptoms</HEADING>
<P>The absence of soiling episodes was reported in 15 (65%) patients when using the PU plug and by 14 (60%) patients when using the PVA plug (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Patient satisfaction</HEADING>
<P>Feelings of security were reported by 16 patients (69%) while using the PU plug and by 10 patients (43%) when using the PVA plug (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). Loss of plug was reported by 7 patients (30%) with the PU plug and by 15 patient 65% with the PVA plug (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>). Inconvenience was reported by 9 patients (39%) when using the PU plug and by 16 (69%) patients when using the PVA plug (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>). Overall satisfaction, defined as patients' opinion that the plug was good to very good, was reported more often for the PU plug (n = 17) than for the PVA plug (n = 8) (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>). 14 patients preferred the PU plug, 5 patients preferred the PVA plug, and 4 patients reported no preference.</P>
<P>No data were available for the other pre-specified outcomes.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3: anal plug versus any other treatment</HEADING>
<P>No eligible trials were found.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-06-16 11:46:10 +0100" MODIFIED_BY="[Empty name]">
<P>This review of anal plugs for the containment of faecal incontinence was limited by the small quantity of eligible studies and participants and the fact that combining data was either impossible or inappropriate. Only one parallel group randomised controlled trial that compared the use of plugs with no intervention could be included (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). The other three included trials were randomised crossover studies. These also reported dropouts and are further limited by not allowing longer-term acceptability rates to be assessed. One such trial compared plug use versus no intervention (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). The other two studies compared two types of plugs. Two sizes of the same plug were investigated in one study (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>); and two brands of plugs were compared in the other study (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>).</P>
<P>Reported outcome measures varied. Two studies reported patient symptoms (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>); one study reported physical measures (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>); two studies reported patient satisfaction (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>); and one study reported the outcome of health status measures and costs (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). There are other variables that may influence the successful wearing of anal plugs, such as leakage rate, skin problems, odour, wearing time, frequency of use, age, social environment and patient characteristics. Unfortunately there were insufficient data in the included studies to take these factors into consideration in our review.</P>
<P>Participant groups also varied between the studies. The participants in two studies suffered from faecal incontinence due to congenital diseases (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>; <LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>). These patients are a minority in the total population of patients with faecal incontinence.</P>
<P>Due to the diversity in comparisons, outcome measures, and type of participants, we were not able to perform a quantitative synthesis of the data but described the data per comparison. This does not allow us to state firm and precise conclusions and emphasizes the need for further research.</P>
<P>The methodological quality of the four included trials was generally poor. Inclusion and exclusion criteria were given in two studies (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>; <LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>); and one study described only inclusion criteria (<LINK REF="STD-Pfrommer-2000" TYPE="STUDY">Pfrommer 2000</LINK>). However, none of the studies provided outcomes related to either severity or frequency of faecal incontinence.</P>
<P>Concealment of allocation was performed in only one study (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). Due to the nature of the intervention of the studies it appeared to be impossible to blind the patients or outcome assessors. Only one trial reported that the researcher who was responsible for the inclusion of patients was securely blinded to the randomisation process (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>).</P>
<P>Incompleteness of follow-up occurred in most trials, caused by selective withdrawal of patients, to a large extent related to intolerance or dissatisfaction with the intervention. An intention-to-treat analysis could be performed in only one trial (<LINK REF="STD-Van-Winckel-2005" TYPE="STUDY">Van Winckel 2005</LINK>). In the study comparing two sizes of anal plugs the high rate of dropout meant that it was not possible to extract data (<LINK REF="STD-Norton-2001b" TYPE="STUDY">Norton 2001b</LINK>). However, it did not appear that there was a difference in dropout rates between studies or patient groups. Most trials studied small patient groups, limiting the power to detect differences between groups.</P>
<P>One trial excluded data from patients who reported that they did not have difficulties with these particular outcomes before or after the intervention (<LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK>). Thus, <LINK REF="STD-Bond-2005" TYPE="STUDY">Bond 2005</LINK> only reported comparisons between the intervention group and control group when the outcome troubled the patient and it was reported as the same, improved or worse. The results presented in this review included data from all the patients. Consequently, our results differ from those published by the author.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-06-16 11:46:14 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-10-22 11:44:38 +0100" MODIFIED_BY="[Empty name]">
<P>This review has focused on the performance of anal plugs for containment of faecal incontinence. The available data were limited and incomplete and not all pre-specified outcomes could be evaluated. Consequently, we can only draw tentative conclusions.</P>
<P>The available data suggest that anal plugs can be difficult to tolerate. For those who do persist, the limited evidence available suggests that plugs may be helpful in alleviating the problems caused by incontinence. In a minority of people with faecal incontinence, plugs could be useful either as a substitute for other forms of management or as an adjuvant treatment option. Plugs come in different designs and sizes; the review showed that the selection of the type of plug can impact on its performance. Specifically, a polyurethane plug performed better than a polyvinyl-alcohol plug in one trial.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-06-16 11:46:14 +0100" MODIFIED_BY="[Empty name]">
<P>This review has illustrated how difficult it is to undertake rigorous evaluations of devices for incontinence. We were only able to extract data from three trials, of which two trials presented small patients groups. Crossover designs are attractive for chronic conditions like intractable faecal incontinence, but the trials reviewed showed high dropout rates (to the extent that in one trial no useful information was generated), and anyway do not allow longer-term performance to be evaluated. Whether or not people persist with using a plug is likely to be a good indication of its value. However, the single parallel group randomised trial that could potentially address this issue illustrated the difficulties of using this design: recruitment proved difficult, and there were more dropouts in the group allocated plugs. This could, therefore, be a scenario where high-quality observational studies could provide useful information. The strength of a randomised controlled trial, however, is that it allows a more reliable assessment of what would happen without the use of plugs; this would clearly be preferable if problems with compliance and retention in the study could be resolved.</P>
<P>There are lessons to be learnt for the design and conduct of future trials. Better reporting of study methods and detailed descriptions of interventions are necessities. Future studies should describe their procedure for blinding, especially in studies where it is quite difficult, if not impossible, to maintain true blinding. Patients will be aware of wearing a plug, and this may affect outcome. While tolerance is a key point in the willingness to use an anal plug, the reasons for patient withdrawal and dropout must be specified and the long-term effects need to be evaluated. Both intention-to-treat analysis and per-protocol analysis should be performed. Sensitivity analyses should explore sensible assumptions about those participants with missing data, for example due to dropout.</P>
<P>When evaluating different plugs, investigators should take into account costs and quality of life, as well as other, specific, advantages and disadvantages of plug use. To avoid bias from socially desired answers from participants, advantages and disadvantages of plug use should be elicited by an independent researcher.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We are grateful to all members of the Cochrane Incontinence Group in Aberdeen (especially to June Cody and Sheila Wallace) for their assistance with the review. Thanks are also due to all authors and to suppliers of anal plugs for their cooperation. Finally we would like to thank Christine Norton for her useful comments on the protocol.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-06-16 11:46:16 +0100" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>The lead reviewer (MD) undertook additional literature searches and contacted authors and manufacturers for additional information when needed. The two reviewers (MD, AD) independently undertook the quality assessment of the trials and the data extraction. The lead reviewer entered the data. This was checked by the other reviewer (AD). Text until the discussion was drafted by the lead reviewer and checked by the other reviewer. Text starting with the discussion was checked by the lead reviewer and drafted by the other reviewer.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Bond-2005" MODIFIED="2015-06-16 12:29:13 +0100" MODIFIED_BY="[Empty name]" NAME="Bond 2005" YEAR="2003">
<REFERENCE MODIFIED="2015-06-16 12:27:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bond C, Youngson G, MacPherson I, Garrett A, Bain N, Donald S, et al</AU>
<TI>Anal plugs for the management of fecal incontinence in children and adults: a randomized control trial</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>2007</YR>
<VL>41</VL>
<NO>1</NO>
<PG>45-53</PG>
<IDENTIFIERS MODIFIED="2015-06-16 12:27:59 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-16 12:27:59 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont22554"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-16 12:29:13 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Also see {6653}&lt;/p&gt;" NOTES_MODIFIED="2015-06-16 12:29:13 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Bond C</AU>
<TI>The anal plug: an evaluation of a novel management option for faecal incontinence</TI>
<SO>Final report to Chief Scientist Office, Scottish Executive Health Department, Edinburgh</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2015-06-16 12:29:13 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-16 12:29:13 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont6653"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Norton-2001b" MODIFIED="2015-06-16 12:29:38 +0100" MODIFIED_BY="[Empty name]" NAME="Norton 2001b" YEAR="2001">
<REFERENCE MODIFIED="2015-06-16 12:29:38 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ref id 19091&lt;/p&gt;" NOTES_MODIFIED="2015-06-16 12:29:38 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Norton C, Kamm MA</AU>
<TI>Anal plug for faecal incontinence</TI>
<SO>Colorectal Disease</SO>
<YR>2001</YR>
<VL>3</VL>
<NO>5</NO>
<PG>323-7</PG>
<IDENTIFIERS MODIFIED="2015-06-16 12:29:38 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-16 12:29:38 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont19091"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pfrommer-2000" MODIFIED="2015-06-16 12:29:59 +0100" MODIFIED_BY="[Empty name]" NAME="Pfrommer 2000" YEAR="2000">
<REFERENCE MODIFIED="2015-06-16 12:29:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;ID: 11013&lt;/p&gt;" NOTES_MODIFIED="2015-06-16 12:29:59 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pfrommer W, Holschneider AM, Loffler N, Schauff B, Ure BM</AU>
<TI>A new polyurethane anal plug in the treatment of incontinence after anal atresia repair</TI>
<SO>European Journal of Pediatric Surgery</SO>
<YR>2000</YR>
<VL>10</VL>
<NO>3</NO>
<PG>186-90</PG>
<IDENTIFIERS MODIFIED="2015-06-16 12:29:59 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-16 12:29:59 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont11013"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Van-Winckel-2005" MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]" NAME="Van Winckel 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-05-27 09:02:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Winckel M, Van Biervliet S, Van Laecke E, Hoebeke P</AU>
<TI>Is an anal plug useful in the treatment of fecal incontinence in children with spina bifida or anal atresia?</TI>
<SO>Journal of Urology</SO>
<YR>2006</YR>
<VL>176</VL>
<NO>1</NO>
<PG>342-4</PG>
<IDENTIFIERS MODIFIED="2015-05-27 09:02:35 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-05-27 09:02:35 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont22027"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Van Winckel M</AU>
<TI>Clinical evaluation of a new anal medical device to achieve faecal continence in spina bifida and anal atresia patients</TI>
<SO>personal communication</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-06-16 12:30:36 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont22025"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-06-16 12:22:55 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-06-16 12:22:55 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Borrie-1992" NAME="Borrie 1992" TYPE="JOURNAL_ARTICLE">
<AU>Borrie MJ, Davidson HA</AU>
<TI>Incontinence in institutions: costs and contributing factors</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1992</YR>
<VL>147</VL>
<NO>3</NO>
<PG>322-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brazzelli-2002" NAME="Brazzelli 2002" NOTES="&lt;p&gt;ref id 14368 - but its really the Cochrane Review Brazzelli M, Shirran E, Vale L. Absorbent products for containing urinary and/or faecal incontinence in adults. The Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001406. DOI: 10.1002/14651858.CD001406.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Brazzelli M, Shirran E, Vale L</AU>
<TI>Absorbent products for containing urinary and/or fecal incontinence in adults</TI>
<SO>Journal of Wound, Ostomy and Continence Nursing</SO>
<YR>2002</YR>
<VL>29</VL>
<NO>1</NO>
<PG>45-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brown-2013" MODIFIED="2015-05-27 08:52:52 +0100" MODIFIED_BY="[Empty name]" NAME="Brown 2013" TYPE="COCHRANE_REVIEW">
<AU>Brown SR, Wadhawan H, Nelson RL</AU>
<TI>Surgery for faecal incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>7</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 08:52:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-05-27 08:52:49 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001757.pub4"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Coggrave-2014" MODIFIED="2015-05-27 08:56:15 +0100" MODIFIED_BY="[Empty name]" NAME="Coggrave 2014" TYPE="COCHRANE_REVIEW">
<AU>Coggrave M, Norton C, Cody JD</AU>
<TI>Management of faecal incontinence and constipation in adults with central neurological diseases</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>1</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 08:56:15 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-05-27 08:56:14 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002115.pub5"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fader-2008" MODIFIED="2015-05-27 08:57:19 +0100" MODIFIED_BY="[Empty name]" NAME="Fader 2008" TYPE="COCHRANE_REVIEW">
<AU>Fader M, Cottenden AM, Getliffe K</AU>
<TI>Absorbent products for moderate-heavy urinary and/or faecal incontinence in women and men</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>4</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 08:57:19 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD007408"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hosker-2007" MODIFIED="2015-05-27 08:58:00 +0100" MODIFIED_BY="[Empty name]" NAME="Hosker 2007" TYPE="COCHRANE_REVIEW">
<AU>Hosker G, Cody JD, Norton CC</AU>
<TI>Electrical stimulation for faecal incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 08:58:00 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD001310.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jorge-1993" NAME="Jorge 1993" TYPE="JOURNAL_ARTICLE">
<AU>Jorge JM, Wexner SD</AU>
<TI>Etiology and management of fecal incontinence</TI>
<SO>Diseases of the Colon &amp; Rectum</SO>
<YR>1993</YR>
<VL>36</VL>
<NO>1</NO>
<PG>77-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kamm-1998" NAME="Kamm 1998" NOTES="&lt;p&gt;ref id 6638&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Kamm MA</AU>
<TI>Faecal incontinence</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>316</VL>
<NO>7130</NO>
<PG>528-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Matzel-2003" NAME="Matzel 2003" TYPE="JOURNAL_ARTICLE">
<AU>Matzel KE, Bittorf B, Stadelmaier U, Hohenberger W</AU>
<TI>Sacral nerve stimulation in the treatment of faecal incontinence</TI>
<SO>Chirurg</SO>
<YR>2003</YR>
<VL>74</VL>
<NO>1</NO>
<PG>26-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mavrantonis-1998" NAME="Mavrantonis 1998" TYPE="JOURNAL_ARTICLE">
<AU>Mavrantonis C, Wexner SD</AU>
<TI>A clinical approach to fecal incontinence</TI>
<SO>Journal of Clinical Gastroenterology</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>2</NO>
<PG>108-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mowatt-2007" MODIFIED="2015-05-27 08:58:54 +0100" MODIFIED_BY="[Empty name]" NAME="Mowatt 2007" TYPE="COCHRANE_REVIEW">
<AU>Mowatt G, Glazener CMA, Jarrett M</AU>
<TI>Sacral nerve stimulation for faecal incontinence and constipation in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 08:58:54 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD004464.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Norton-2001a" NAME="Norton 2001a" NOTES="&lt;p&gt;ref id 19091&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Norton C, Kamm MA</AU>
<TI>Anal plug for faecal incontinence</TI>
<SO>Colorectal Disease</SO>
<YR>2001</YR>
<VL>3</VL>
<NO>5</NO>
<PG>323-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norton-2012" MODIFIED="2015-05-27 09:00:32 +0100" MODIFIED_BY="[Empty name]" NAME="Norton 2012" TYPE="COCHRANE_REVIEW">
<AU>Norton C, Cody JD</AU>
<TI>Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>7</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 09:00:17 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-05-27 09:00:17 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002111.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Omar-2013" MODIFIED="2015-05-27 08:54:44 +0100" MODIFIED_BY="[Empty name]" NAME="Omar 2013" TYPE="COCHRANE_REVIEW">
<AU>Omar MI, Alexander CE</AU>
<TI>Drug treatment for faecal incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>6</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2015-05-27 08:54:44 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-05-27 08:54:42 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002116.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Perry-2002" NAME="Perry 2002" NOTES="&lt;p&gt;ref id 13058&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Perry S, Shaw C, McGrother C, Matthews RJ, Assassa RP, Dallosso H, et al</AU>
<TI>Prevalence of faecal incontinence in adults aged 40 years or more living in the community</TI>
<SO>Gut</SO>
<YR>2002</YR>
<VL>50</VL>
<NO>4</NO>
<PG>480-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reference-Manager-2012" MODIFIED="2015-05-27 08:39:04 +0100" MODIFIED_BY="[Empty name]" NAME="Reference Manager 2012" TYPE="OTHER">
<TI>Reference Manager Professional Edition Version 12</TI>
<SO>New York: Thomson Reuters</SO>
<YR>2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2003" MODIFIED="2015-06-16 12:22:55 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2003" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2003</YR>
<EN>4.2.5</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Soffer-2000" MODIFIED="2015-05-27 09:01:37 +0100" MODIFIED_BY="[Empty name]" NAME="Soffer 2000" TYPE="JOURNAL_ARTICLE">
<AU>Soffer EE, Hull T</AU>
<TI>Fecal incontinence: a practical approach to evaluation and treatment</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2000</YR>
<VL>95</VL>
<PG>1873-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Toglia-1998" NAME="Toglia 1998" TYPE="JOURNAL_ARTICLE">
<AU>Toglia MR</AU>
<TI>Pathophysiology of anorectal dysfunction</TI>
<SO>Obstetrics and Gynecology Clinics of North America</SO>
<YR>1998</YR>
<VL>25</VL>
<NO>4</NO>
<PG>771-81</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-03-12 12:18:14 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Deutekom-2005" MODIFIED="2012-03-12 12:18:14 +0000" MODIFIED_BY="[Empty name]" NAME="Deutekom 2005" TYPE="COCHRANE_REVIEW">
<AU>Deutekom M, Dobben AC</AU>
<TI>Plugs for containing faecal incontinence</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-03-12 12:18:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-03-12 12:18:14 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005086.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2009-06-25 14:42:27 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-06-17 11:00:14 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-06-17 11:00:14 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-06-17 11:00:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bond-2005">
<CHAR_METHODS>
<P>Randomised controlled trial (2:1)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-16 11:46:20 +0100" MODIFIED_BY="[Empty name]">
<P>Forty eight patients took part in the trial (28 children, age &gt; 4 years; and 20 young adults, age 16 to 45 years)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-16 11:46:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Polyurethane anal plug (Conveen, Coloplast) (two sizes)<BR/>2. no intervention</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-16 11:46:23 +0100" MODIFIED_BY="[Empty name]">
<P>- Functional Status II-R -SF-36</P>
<P>- a Patient-Generated Index of Quality of Life (PGI)</P>
<P>- a Carer-Generated Index (CGI) of Quality of Life</P>
<P>- the Dartmouth COOP Charts</P>
<P>- a condition-</P>
<P>specific measure developed for the research</P>
<P>- qualitative data: advantages and disadvantages of the plug</P>
<P>- health service utilisation data</P>
<P>- costs data</P>
<P>- evaluation of education package</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-17 11:00:14 +0100" MODIFIED_BY="[Empty name]">
<P>31
 (16 children and 15 adults) allocated plugs; 17
 (12
 children and 5 adults) allocated to no plugs.<BR/>6 participants did not complete the trial (5 in plug group and 1 in control group).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-16 11:47:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Norton-2001b">
<CHAR_METHODS>
<P>Randomised cross-over trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-16 11:47:09 +0100" MODIFIED_BY="[Empty name]">
<P>Adult outpatients (n = 34) attending a specialist colorectal hospital after failure of previous treatment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-16 11:47:14 +0100" MODIFIED_BY="[Empty name]">
<P>1. Polyurethane anal plug (Conveen, Coloplast) 37 mm diameter when open<BR/>2. Polyurethane anal plug (Conveen, Coloplast) 45 mm diameter when open</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-16 11:47:19 +0100" MODIFIED_BY="[Empty name]">
<P>- comfort of inserting plug</P>
<P>- comfort of plug in use</P>
<P>- comfort of taking plug out</P>
<P>- capacity of controlling faecal leakage</P>
<P>- preference</P>
<P>- patient characteristics which predict when the plug will help the most</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-16 11:47:20 +0100" MODIFIED_BY="[Empty name]">
<P>Of the 34 patients offered the plug, 4 refused as they disliked the idea, 2 failed to attend, 8 dropped out after trying first plug, because of discomfort and 9 dropped out after trying one size of plug, refusing to try the second size. 11 patients completed the protocol.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-16 11:47:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pfrommer-2000">
<CHAR_METHODS>
<P>Randomised cross-over trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-16 11:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>38 partially continent or incontinent patients following imperforate anus repair (age &gt; 6 to 15)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-16 11:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>1. Polyurethane anal plug (Conveen, Coloplast) (size closed/open diameter of 14.5/38mm or 15.5/45mm; depending on anal canal diameter)<BR/>2. EFF-EFF polyvinyl-alcohol plug (Med. SSE-System) (diameters ranging from 15mm to 38mm. Used size dependent on anal canal diameter)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-16 11:47:29 +0100" MODIFIED_BY="[Empty name]">
<P>- stool consistency<BR/>- awareness of repletion<BR/>- effectiveness of treatment<BR/>- feeling of security<BR/>- loss of plug<BR/>- inconvenience<BR/>- overall satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-16 11:47:30 +0100" MODIFIED_BY="[Empty name]">
<P>38 patients included.<BR/>Drop-out:<BR/>- 2 patients liked first tested product<BR/>- 6 patients found the smallest available size of the products tested first too big<BR/>- 2 patients reported discomfort<BR/>- 1 patient constantly lost one of the products<BR/>- 4 patients failed to complete the protocol for non-plug related reasons<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-16 11:47:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Winckel-2005">
<CHAR_METHODS>
<P>Randomised cross-over trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-16 11:47:31 +0100" MODIFIED_BY="[Empty name]">
<P>7 patients (4 to 12 yrs; 3 girls and 4 boys) with high type of imperforate anus; and 9 patients with spina bifida (6 to 13 yrs, 2 girls and 7 boys)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-16 11:47:31 +0100" MODIFIED_BY="[Empty name]">
<P>1. Polyurethane anal plug (Conveen, Coloplast) (size 12 or 13mm; depending on preference).<BR/>2. no intervention</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-16 11:47:35 +0100" MODIFIED_BY="[Empty name]">
<P>- number of stools<BR/>- number of soiling episodes<BR/>- number of diapers or pads used<BR/>- number of plugs<BR/>- satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-16 11:47:36 +0100" MODIFIED_BY="[Empty name]">
<P>16 patients included.<BR/>- 2 (patients with imperforate anus) dropped-out due to discomfort and pain<BR/>- 2 (patients with spina bifida) dropped out because of losing the plug<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Bond-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Norton-2001b">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pfrommer-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Van-Winckel-2005">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-06-17 11:01:45 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2015-06-17 11:01:45 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Anal plugs versus no plugs</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-15 13:27:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>General health improved - adults</NAME>
<GROUP_LABEL_1>Plug use</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plug use</GRAPH_LABEL_2>
<DICH_DATA CI_END="43.63240889305693" CI_START="0.15792446887103861" EFFECT_SIZE="2.625" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.639809190527107" LOG_CI_START="-0.8015505750431559" LOG_EFFECT_SIZE="0.4191293077419757" ORDER="1100" O_E="0.0" SE="1.4340668112217154" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="2.056547619047619" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-15 13:27:56 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Bodily pain improved - adults</NAME>
<GROUP_LABEL_1>Plug use</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plug use</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.718217544574392" CI_START="0.25866599130468937" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.23507814926646298" LOG_CI_START="-0.5872606673778256" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="1101" O_E="0.0" SE="0.48304589153964794" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.23333333333333334" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="41" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-15 13:28:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="135" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Well being (adults) improved</NAME>
<GROUP_LABEL_1>Plug use</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plug use</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Full of life</NAME>
<DICH_DATA CI_END="7.570371178018677" CI_START="0.13209391937129836" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="0.8791171736365839" LOG_CI_START="-0.8791171736365839" LOG_EFFECT_SIZE="0.0" ORDER="1102" O_E="0.0" SE="1.0327955589886444" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="1.0666666666666667" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="0" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Very nervous</NAME>
<DICH_DATA CI_END="73.93847864403399" CI_START="0.321424317024646" EFFECT_SIZE="4.875" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="1.8688705102985101" LOG_CI_START="-0.4929212702293989" LOG_EFFECT_SIZE="0.6879746200345557" ORDER="1103" O_E="0.0" SE="1.3873281829399584" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="1.924679487179487" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Down in the dumps</NAME>
<DICH_DATA CI_END="0.7532478029295164" CI_START="0.08297402230305383" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="-0.1230621264013413" LOG_CI_START="-1.0810578562545836" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="1104" O_E="0.0" SE="0.5627314338711377" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.3166666666666666" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="1" I2="0.0" ID="CMP-001.03.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-15 13:28:24 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Calm and peaceful</NAME>
<DICH_DATA CI_END="9.311446002734531" CI_START="0.19092392065160343" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="0.9690171291279145" LOG_CI_START="-0.7191396559113146" LOG_EFFECT_SIZE="0.12493873660829993" ORDER="1105" O_E="0.0" SE="0.9916316520429012" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.9833333333333334" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-001.03.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Lot of energy</NAME>
<DICH_DATA CI_END="3.454197176819389" CI_START="0.2895028710899463" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.5383471248818377" LOG_CI_START="-0.5383471248818377" LOG_EFFECT_SIZE="0.0" ORDER="1106" O_E="0.0" SE="0.6324555320336759" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.39999999999999997" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-001.03.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Downhearted and low</NAME>
<DICH_DATA CI_END="3.0279465654077513" CI_START="0.2293450130124501" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="0.48114820684080994" LOG_CI_START="-0.6395106989360596" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="1107" O_E="0.0" SE="0.6582805886043833" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.4333333333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.03.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Feel worn out</NAME>
<DICH_DATA CI_END="1.785682317953818" CI_START="0.06222333614101716" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.2518041982079043" LOG_CI_START="-1.2060467076472292" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="1108" O_E="0.0" SE="0.8563488385776753" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.7333333333333334" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="1" I2="0.0" ID="CMP-001.03.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Happy</NAME>
<DICH_DATA CI_END="11.071018239312199" CI_START="0.25090535646614115" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.0441875662606448" LOG_CI_START="-0.6004900670279322" LOG_EFFECT_SIZE="0.2218487496163564" ORDER="1109" O_E="0.0" SE="0.9660917830792959" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.9333333333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="1" I2="0.0" ID="CMP-001.03.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="5" WEIGHT="0.0" Z="0.0">
<NAME>Tired</NAME>
<DICH_DATA CI_END="14.61316833277667" CI_START="0.3725711167120962" EFFECT_SIZE="2.3333333333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.1647443870680674" LOG_CI_START="-0.42879081647887846" LOG_EFFECT_SIZE="0.36797678529459443" ORDER="1110" O_E="0.0" SE="0.9360504666899516" STUDY_ID="STD-Bond-2005" TOTAL_1="15" TOTAL_2="5" VAR="0.8761904761904762" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="90" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-17 11:01:45 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="297" TOTAL_2="165" WEIGHT="0.0" Z="0.0">
<NAME>Condition-specific measures of faecal incontinence improved</NAME>
<GROUP_LABEL_1>Plug use</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plug use</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="1" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Protection</NAME>
<DICH_DATA CI_END="32.213283626598766" CI_START="0.61319692362696" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.5080349964194433" LOG_CI_START="-0.2124000326421683" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="1111" O_E="0.0" SE="1.0105920523615335" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="1.0212962962962964" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Rash/skin problems</NAME>
<DICH_DATA CI_END="5.3710619641393205" CI_START="0.2298554567937106" EFFECT_SIZE="1.1111111111111112" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.730060162714087" LOG_CI_START="-0.6385451815927368" LOG_EFFECT_SIZE="0.04575749056067514" ORDER="1112" O_E="0.0" SE="0.8039255539515436" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.6462962962962964" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="4" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Unpleasant odour</NAME>
<DICH_DATA CI_END="3.3788581164112017" CI_START="0.4624343331881552" EFFECT_SIZE="1.25" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.52876995544657" LOG_CI_START="-0.33494992943045715" LOG_EFFECT_SIZE="0.09691001300805642" ORDER="1113" O_E="0.0" SE="0.50735333585915" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.2574074074074074" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="4" I2="0.0" ID="CMP-001.04.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Staining/smearing</NAME>
<DICH_DATA CI_END="4.263260353767465" CI_START="0.6515618440527662" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="4" LOG_CI_END="0.6297418554601584" LOG_CI_START="-0.18604435622744567" LOG_EFFECT_SIZE="0.2218487496163564" ORDER="1114" O_E="0.0" SE="0.4791968589521739" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.22962962962962963" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="5" I2="0.0" ID="CMP-001.04.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2009-07-16 13:14:24 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Bowel movement in undergarments (last two weeks)</NAME>
<DICH_DATA CI_END="3.2656361058568018" CI_START="0.6389014836480098" EFFECT_SIZE="1.4444444444444444" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="5" LOG_CI_END="0.5139677890891954" LOG_CI_START="-0.19456610335417154" LOG_EFFECT_SIZE="0.15970084286751188" ORDER="1115" O_E="0.0" SE="0.41619631572056626" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.17321937321937325" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="1" I2="0.0" ID="CMP-001.04.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Frequency of unpleasant odours</NAME>
<DICH_DATA CI_END="32.213283626598766" CI_START="0.61319692362696" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.5080349964194433" LOG_CI_START="-0.2124000326421683" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="1116" O_E="0.0" SE="1.0105920523615335" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="1.0212962962962964" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="5" I2="0.0" ID="CMP-001.04.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-17 11:01:33 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Bowel movements in undergarments (on average day)</NAME>
<DICH_DATA CI_END="2.234965901977768" CI_START="0.3535281930211672" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.3492709016532514" LOG_CI_START="-0.45157594654801403" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="1117" O_E="0.0" SE="0.47042140288925666" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.22129629629629632" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="1" I2="0.0" ID="CMP-001.04.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-17 11:01:45 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Soiled/stained undergarment (on average day)</NAME>
<DICH_DATA CI_END="39.29626525787739" CI_START="0.7854231777071262" EFFECT_SIZE="5.555555555555555" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="1" LOG_CI_END="1.5943512767120769" LOG_CI_START="-0.10489628691868898" LOG_EFFECT_SIZE="0.7447274948966939" ORDER="1118" O_E="0.0" SE="0.9981464302878092" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.9962962962962965" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="7" I2="0.0" ID="CMP-001.04.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Prevents staying away from home</NAME>
<DICH_DATA CI_END="1.158640543145555" CI_START="0.1957098523403094" EFFECT_SIZE="0.47619047619047616" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.06394872125981577" LOG_CI_START="-0.7083873107276543" LOG_EFFECT_SIZE="-0.3222192947339193" ORDER="1119" O_E="0.0" SE="0.4536740083144568" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="0.20582010582010585" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="1" I2="0.0" ID="CMP-001.04.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Must avoid long journeys</NAME>
<DICH_DATA CI_END="18.118755139054603" CI_START="0.2725502699848253" EFFECT_SIZE="2.2222222222222223" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.258128355878803" LOG_CI_START="-0.5645533834294904" LOG_EFFECT_SIZE="0.3467874862246563" ORDER="1120" O_E="0.0" SE="1.0706522760898127" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="1.1462962962962964" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="1" I2="0.0" ID="CMP-001.04.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Must always have a toilet nearby</NAME>
<DICH_DATA CI_END="32.213283626598766" CI_START="0.61319692362696" EFFECT_SIZE="4.444444444444445" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.5080349964194433" LOG_CI_START="-0.2124000326421683" LOG_EFFECT_SIZE="0.6478174818886375" ORDER="1121" O_E="0.0" SE="1.0105920523615335" STUDY_ID="STD-Bond-2005" TOTAL_1="27" TOTAL_2="15" VAR="1.0212962962962964" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-001.05" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Stool frequency</NAME>
<TR>
<TH/>
</TR>
<OTHER_DATA ORDER="23" STUDY_ID="STD-Bond-2005">
<TR>
<TD>
<P>No differences were observed between control and intervention group</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="1" ID="CMP-001.06" NO="6" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Costs</NAME>
<TR>
<TH/>
</TR>
<OTHER_DATA ORDER="24" STUDY_ID="STD-Bond-2005">
<TR>
<TD>
<P>Little or no evidence that the plug led to significant reductions in the overall costs of care</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-001.07" NO="7" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Achievement of pseudo-continence</NAME>
<TR>
<TH>
<P>Anal plug period</P>
</TH>
<TH>
<P>Control period</P>
</TH>
</TR>
<OTHER_DATA ORDER="25" STUDY_ID="STD-Van-Winckel-2005">
<TR>
<TD>
<P>6/12</P>
</TD>
<TD>
<P>0/12</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-001.08" NO="8" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Intolerance of intervention</NAME>
<TR>
<TH>
<P>Anal plug period</P>
</TH>
<TH>
<P>Control period</P>
</TH>
</TR>
<OTHER_DATA ORDER="26" STUDY_ID="STD-Van-Winckel-2005">
<TR>
<TD>
<P>4/16</P>
</TD>
<TD>
<P>0/16</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>One type of anal plug versus another type</NAME>
<OTHER_OUTCOME COLS="2" ID="CMP-002.01" NO="1" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Plug effectiveness: number of people with no soiling</NAME>
<TR>
<TH>
<P>PU plug</P>
</TH>
<TH>
<P>PVA plug</P>
</TH>
</TR>
<OTHER_DATA ORDER="27" STUDY_ID="STD-Pfrommer-2000">
<TR>
<TD>
<P>15/23</P>
</TD>
<TD>
<P>14/23</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-002.02" NO="2" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Feeling of security</NAME>
<TR>
<TH>
<P>PU plug</P>
</TH>
<TH>
<P>PVA plug</P>
</TH>
</TR>
<OTHER_DATA ORDER="28" STUDY_ID="STD-Pfrommer-2000">
<TR>
<TD>
<P>16/23</P>
</TD>
<TD>
<P>10/23</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-002.03" NO="3" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Loss of plug</NAME>
<TR>
<TH>
<P>PU plug</P>
</TH>
<TH>
<P>PVA plug</P>
</TH>
</TR>
<OTHER_DATA ORDER="29" STUDY_ID="STD-Pfrommer-2000">
<TR>
<TD>
<P>7/23</P>
</TD>
<TD>
<P>15/23</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-002.04" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Inconvenience</NAME>
<TR>
<TH>
<P>PU plug</P>
</TH>
<TH>
<P>PVA plug</P>
</TH>
</TR>
<OTHER_DATA ORDER="30" STUDY_ID="STD-Pfrommer-2000">
<TR>
<TD>
<P>9/23</P>
</TD>
<TD>
<P>16/23</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="2" ID="CMP-002.05" NO="5" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Overall satisfaction</NAME>
<TR>
<TH>
<P>PU plug</P>
</TH>
<TH>
<P>PVA plug</P>
</TH>
</TR>
<OTHER_DATA ORDER="31" STUDY_ID="STD-Pfrommer-2000">
<TR>
<TD>
<P>17/23</P>
</TD>
<TD>
<P>8/23</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Anal plugs versus any other treatment</NAME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-03-12 12:03:23 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-03-12 12:03:23 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAMuCAYAAAAzFYXdAABVaUlEQVR42u2dDYRV2//GfyRJkkiS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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-05-27 09:09:03 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-05-27 09:09:03 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-05-27 09:08:49 +0100" MODIFIED_BY="[Empty name]">Cochrane Incontinence Group Specialised Register search terms</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-27 09:09:03 +0100" MODIFIED_BY="[Empty name]">
<P>The Incontinence Group Specialised Register was searched using the Group's own keyword system. The search terms used were:</P>
<P>(design.rct* or design.cct*)<BR/>AND<BR/>({INTVENT.MECH.DEVICE.ANAL.TAMPON} OR {INTVENT.MECH.device.pessaries.} OR {INTVENT.MECH.DEVICE.PLUG.} OR {INTVENT.MECH.DEVICE.PLUG.anal.} OR {INTVENT.MECH.DEVICE.VAGINAL.*} OR {INTVENT.MECH.DEVICES.} OR {INTVENT.MECH.devices.pessaries.} OR {INTVENT.MECH.})</P>
<P>(All searches were of the keyword field of <LINK REF="REF-Reference-Manager-2012" TYPE="REFERENCE">Reference Manager 2012</LINK>).</P>
<P>Date of the most recent search of the register for this review: 26 May 2015.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-05-27 09:08:57 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2009-06-25 14:05:42 +0100" MODIFIED_BY="[Empty name]">Search methods for the first published version of this review</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-27 09:06:14 +0100" MODIFIED_BY="[Empty name]">
<P>For the first version of this review (<LINK REF="REF-Deutekom-2005" TYPE="REFERENCE">Deutekom 2005</LINK>) the authors performed the following additional searches. All searches were carried out on 26 November 2004. The following electronic bibliographic databases were searched: MEDLINE (January 1966 to November 2004); CINAHL (January 1982 to November Week 3 2004); EMBASE (January 1996 to 2004 Week 47); INVERT (Dutch nursing database - Index van de Nederlandstalige Verpleegkundige Tijdschriftliteratuur) (January 1993 to November 2004); and Web of Science (January 1988 to November 2004).<BR/>The following search terms were used:<BR/>1.tampon*<BR/>2.plug*<BR/>3.incontinen*<BR/>4.stool*<BR/>5.faec*<BR/>6.fecal incontinence/ [mesh]<BR/>7.flatus [mesh] OR anal [mesh]<BR/>8.anus OR anal<BR/>9.(1 or 2) AND (3 or 4 or 5 or 6 or 7 or 8)<BR/>Key: * = truncation symbol.<BR/>Additionally all reference lists of identified trials were searched.</P>
<P>We contacted two manufacturers that marketed plugs to ask for details of unpublished or ongoing trials. We did not impose any language or other limitations on the searches.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 reports of 1 study (&lt;a link_type=&quot;STUDY&quot; href=&quot;Bond 2005&quot; protected=&quot;true&quot;&gt;Bond 2005&lt;/a&gt;) were included in the quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;6 reports of 4 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;6 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;15 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;15 records after duplicates removed&lt;/p&gt;" WIDTH="200">
<FLOWCHARTBOX TEXT="&lt;p&gt;7 records identified through searching the Specialised Register&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;8 additional records identified through other sources including: &lt;a link_type=&quot;STUDY&quot; href=&quot;Norton 2001b&quot; protected=&quot;true&quot;&gt;Norton 2001b&lt;/a&gt; author search; &lt;a link_type=&quot;STUDY&quot; href=&quot;Van Winckel 2005&quot; protected=&quot;true&quot;&gt;Van Winckel 2005&lt;/a&gt; from manufacturer&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;9 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;0 full-text articles excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>